| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.07B | +69.4% |
| Cost of Revenue | $717.5M | +56.5% |
| Gross Profit | $1.35B | +77.2% |
| R&D Expense | $788.1M | +68.8% |
| SG&A Expense | $295.8M | +11.6% |
| Operating Income | -$842.3M | -17.8% |
| Pre-tax Income | -$816.0M | -20.5% |
| Income Tax | -$18.5M | -718.0% |
| Net Income | -$796.7M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $939.9M | -13.4% |
| Accounts Receivable | $715.8M | +31.2% |
| Current Assets | $4.98B | +8.4% |
| Total Assets | $7.72B | +16.1% |
| Current Liabilities | $1.99B | +42.7% |
| Total Liabilities | $2.25B | +40.8% |
| Stockholders' Equity | $5.46B | +8.1% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $545.6M | +395.2% |
| Capital Expenditures | $25.1M | +54.9% |
| Investing Cash Flow | -$597.9M | -2774.4% |
| Financing Cash Flow | -$92.6M | -152.0% |
| Free Cash Flow | $520.5M | +454.0% |
| -17.2% |
| EPS (Basic) | -$2.50 | -10.6% |
| EPS (Diluted) | -$2.50 | -10.6% |